Cancer Research and Treatment

Vascular Endothelial Growth Factor Receptor Inhibitors for Recurrent or Metastatic Adenoid Cystic Carcinoma

Camilla O. Hoff, Joao Manzi, Felippe Lazar Neto, Renata Ferrarotto

JAMA Otolaryngology–Head & Neck Surgery.2024; 150(7): 587. CrossRef

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma

Parisa Bayat, Nazanin Mahdavi, Shima Younespour, Neda Kardouni Khoozestani

Clinical and Experimental Dental Research.2023; 9(1): 112. CrossRef

Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy

Quan-Quan Lin, Jin-Long Sun, Feng Wang, Hai-Zhong Zhang, Ge Zhou, Qing Xi

Holistic Integrative Oncology.2023;[Epub] CrossRef

Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma

Alessandro Marchioni, Roberto Tonelli, Anna Valeria Samarelli, Gaia Francesca Cappiello, Alessandro Andreani, Luca Tabbì, Francesco Livrieri, Annamaria Bosi, Ottavia Nori, Francesco Mattioli, Giulia Bruzzi, Daniele Marchioni, Enrico Clini

International Journal of Molecular Sciences.2023; 24(14): 11370. CrossRef

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma

Glenn J. Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong, Alan L. Ho, Sung-Bae Kim, Francis Worden, Tak Yun, Xianzhang Meng, Jan M. Van Tornout, Maureen G. Conlan, Hyunseok Kang

Clinical Cancer Research.2023; 29(22): 4555. CrossRef

A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma

Lauren E. Miller, Vivienne Au, Tara E. Mokhtari, Deborah Goss, Daniel L. Faden, Mark A. Varvares

Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma

Luana Guimaraes de Sousa, Felippe Lazar Neto, Jessica Lin, Renata Ferrarotto

Current Oncology Reports.2022; 24(5): 621. CrossRef

Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments

Luana Guimaraes de Sousa, Katarina Jovanovic, Renata Ferrarotto

Current Treatment Options in Oncology.2022; 23(8): 1135. CrossRef

The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?

Robbert Cleymaet, Tijl Vermassen, Renaat Coopman, Hubert Vermeersch, Stijn De Keukeleire, Sylvie Rottey

International Journal of Molecular Sciences.2022; 23(23): 14891. CrossRef

Approaches to the Management of Metastatic Adenoid Cystic Carcinoma

Rex H. Lee, Katherine C. Wai, Jason W. Chan, Patrick K. Ha, Hyunseok Kang

Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy

James Nightingale, Benedict Lum, Rahul Ladwa, Fiona Simpson, Benedict Panizza

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1875(2): 188523. CrossRef

Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study

Guopei Zhu, Lin Zhang, Shengjin Dou, Rongrong Li, Jiang Li, Lulu Ye, Wen Jiang, Minjun Dong, Min Ruan, Wenjun Yang, Chenping Zhang

Therapeutic Advances in Medical Oncology.2021;[Epub] CrossRef

Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis

Erison Santana dos Santos, Carla Isabelly Rodrigues-Fernandes, Paul M. Speight, Syed Ali Khurram, Ibrahim Alsanie, Ana Gabriela Costa Normando, Ana Carolina Prado-Ribeiro, Thaís Bianca Brandão, Luiz Paulo Kowalski, Eliete Neves Silva Guerra, Marcio Ajudar

Critical Reviews in Oncology/Hematology.2021; 162: 103352. CrossRef

Molecular Markers that Matter in Salivary Malignancy

Otolaryngologic Clinics of North America.2021; 54(3): 613. CrossRef

C. V. Divyambika, K. Satish Srinivas, S. Sathasiva Subramanian, S. Elengkumaran, N. Malathi

Indian Journal of Dental Research.2021; 32(1): 120. CrossRef

Anlotinib is effective in patients with advanced oral cancer?

Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression

R. Cordesmeyer, R. Laskawi, H. Schliephake, P. Kauffmann, J. Beck, K. Bornemann-Kolatzki, E. Schütz, P. Ströbel, S. Kueffer, A. Fichtner, F. Bremmer

Knockdown Rab11‐FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling

Guofei Feng, Liting Qin, Zhipeng Liao, Xiling Xiao, Bo Li, Wanmeng Cui, Libin Liang, Yingxi Mo, Guangwu Huang, Ping Li, Xiaoying Zhou, Zhe Zhang, Xue Xiao

Journal of Cellular Biochemistry.2020; 121(2): 1072. CrossRef

Gemma Gatta, Marco Guzzo, Laura D. Locati, Mark McGurk, Franz Josef Prott

Critical Reviews in Oncology/Hematology.2020; 152: 102959. CrossRef

The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis

Current Opinion in Oncology.2019; 31(3): 169. CrossRef

Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma

A.L. Ho, L. Dunn, E.J. Sherman, M.G. Fury, S.S. Baxi, R. Chandramohan, S. Dogan, L.G.T. Morris, G.D. Cullen, S. Haque, C.S. Sima, A. Ni, C.R. Antonescu, N. Katabi, D.G. Pfister

The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis

Jun Ju, Yun Li, Juan Chai, Chao Ma, Qianwei Ni, Zhiyuan Shen, Jianhua Wei, Moyi Sun

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2016; 122(6): 691. CrossRef